Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chunjuan Du"'
Autor:
Chunjuan Du, Tongxin Yan
Publikováno v:
AIMS Mathematics, Vol 8, Iss 9, Pp 19876-19891 (2023)
In this paper, we propose a class of successive over relaxation-based alternately linearized implicit iteration method for computing the minimal nonnegative solution of nonsymmetric algebraic Riccati equations. Under certain conditions, we prove the
Externí odkaz:
https://doaj.org/article/07b172501b0c4d5792402391a6111ee8
Autor:
Chunjuan, Du, Xia, Han, Yanyan, Zhang, Fengli, Guo, Haibin, Yuan, Feng, Wang, Mianli, Li, Fangling, Ning, Weibo, Wang
Publikováno v:
Open Medicine. 17:2036-2045
The long noncoding RNA DARS-AS1 was aberrantly expressed and participated in several human cancer progressions, whereas whether DARS-AS1 is involved in human gastric cancer remains unclear. This study aimed to investigate the influence of DARS-AS1 on
Autor:
Mianli Li, Feng Wang, Chen Yinghai, Chunjuan Du, Baosheng Li, Han Xia, Chang-Min Liu, Juan Wang, Shaoshui Chen, Xiaofei Zhong
Publikováno v:
Cancer Biomarkers. 25:325-332
Background Lung cancer is the main cancer-related deaths worldwide. In this study, we explored the clinical prognostic significance and functional role of miR-939-3p in lung cancer. Methods We analyzed the expression of miR-939-3p in lung cancer tiss
Publikováno v:
Journal of Cancer
Background Cytokine-induced killer (CIK) cells can potentially enhance the tumor-killing activity of chemotherapy. Objective This study aimed to evaluate the effects of CIK cells on cisplatin (DDP) resistance in the human lung adenocarcinoma cell lin
Autor:
Chunjuan Du1, Hongshun Ma2, Min Ruo2, Zhongjun Zhang2, Xiaojun Yu3, Yanjun Zeng1 yjzeng@bjpu.edu.cn
Publikováno v:
Bio-Medical Materials & Engineering. 2006, Vol. 16 Issue 3, p215-222. 8p. 6 Charts, 2 Graphs.
Autor:
Liang Liu, Xishan Hao, Chunjuan Du, Shui Cao, Hui Li, Jinpu Yu, Shizhen Emily Wang, Changli Wang, Xiubao Ren, Runmei Li
Publikováno v:
Cancer immunology, immunotherapy : CII. 61(11)
Cytokine-induced killer (CIK) cells have the ability to kill tumor in vitro and in vivo. This study was designed to evaluate the clinical efficacy of CIK cell immunotherapy following regular chemotherapy in patients with non-small cell lung cancer (N